Moncyte R&D team from University of Helsinki has developed a unique solution that sheds light on why some people respond differently to cholesterol-lowering drugs.
Moncyte targets optimal cholesterol-lowering therapy Read More »
Presenting Health Incubator Helsinki batch 3 companies: Helsinki startup Fepod wants to help healthcare professionals measure the real blood concentration of paracetamol, opioids, and other pain medicine directly from a
Fepod flips the script on blood analytics Read More »
Finnish-French molecular diagnostics company Mobidiag Oy is to be acquired by Hologic, Inc., a global leader in women’s health, for approximately €668 million. The transaction will accelerate global growth of Mobidiag’s
Diagnostics company Mobidiag to be aqcuired for approx. €668M Read More »
